Literature DB >> 10825186

p53 regulation of G(2) checkpoint is retinoblastoma protein dependent.

P M Flatt1, L J Tang, C D Scatena, S T Szak, J A Pietenpol.   

Abstract

In the present study, we investigated the role of p53 in G(2) checkpoint function by determining the mechanism by which p53 prevents premature exit from G(2) arrest after genotoxic stress. Using three cell model systems, each isogenic, we showed that either ectopic or endogenous p53 sustained a G(2) arrest activated by ionizing radiation or adriamycin. The mechanism was p21 and retinoblastoma protein (pRB) dependent and involved an initial inhibition of cyclin B1-Cdc2 activity and a secondary decrease in cyclin B1 and Cdc2 levels. Abrogation of p21 or pRB function in cells containing wild-type p53 blocked the down-regulation of cyclin B1 and Cdc2 expression and led to an accelerated exit from G(2) after genotoxic stress. Thus, similar to what occurs in p21 and p53 deficiency, pRB loss can uncouple S phase and mitosis after genotoxic stress in tumor cells. These results indicate that similar molecular mechanisms are required for p53 regulation of G(1) and G(2) checkpoints.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10825186      PMCID: PMC85790          DOI: 10.1128/MCB.20.12.4210-4223.2000

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  62 in total

1.  Constitutive activation of cyclin B1-associated cdc2 kinase overrides p53-mediated G2-M arrest.

Authors:  M Park; H D Chae; J Yun; M Jung; Y S Kim; S H Kim; M H Han; D Y Shin
Journal:  Cancer Res       Date:  2000-02-01       Impact factor: 12.701

2.  The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F.

Authors:  S W Hiebert; S P Chellappan; J M Horowitz; J R Nevins
Journal:  Genes Dev       Date:  1992-02       Impact factor: 11.361

Review 3.  Checkpoints: controls that ensure the order of cell cycle events.

Authors:  L H Hartwell; T A Weinert
Journal:  Science       Date:  1989-11-03       Impact factor: 47.728

4.  Oncogenic forms of p53 inhibit p53-regulated gene expression.

Authors:  S E Kern; J A Pietenpol; S Thiagalingam; A Seymour; K W Kinzler; B Vogelstein
Journal:  Science       Date:  1992-05-08       Impact factor: 47.728

5.  p53 is required for radiation-induced apoptosis in mouse thymocytes.

Authors:  S W Lowe; E M Schmitt; S W Smith; B A Osborne; T Jacks
Journal:  Nature       Date:  1993-04-29       Impact factor: 49.962

6.  Mechanisms of G2 arrest in response to overexpression of p53.

Authors:  W R Taylor; S E DePrimo; A Agarwal; M L Agarwal; A H Schönthal; K S Katula; G R Stark
Journal:  Mol Biol Cell       Date:  1999-11       Impact factor: 4.138

7.  Participation of p53 protein in the cellular response to DNA damage.

Authors:  M B Kastan; O Onyekwere; D Sidransky; B Vogelstein; R W Craig
Journal:  Cancer Res       Date:  1991-12-01       Impact factor: 12.701

8.  Inactivation of the p34cdc2-cyclin B complex by the human WEE1 tyrosine kinase.

Authors:  L L Parker; H Piwnica-Worms
Journal:  Science       Date:  1992-09-25       Impact factor: 47.728

9.  Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis.

Authors:  S W Lowe; H E Ruley
Journal:  Genes Dev       Date:  1993-04       Impact factor: 11.361

10.  Cell cycle regulation of the human cdc2 gene.

Authors:  S Dalton
Journal:  EMBO J       Date:  1992-05       Impact factor: 11.598

View more
  47 in total

1.  p53 down-regulates CHK1 through p21 and the retinoblastoma protein.

Authors:  V Gottifredi; O Karni-Schmidt; S S Shieh; C Prives
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

2.  Inactivation of p21 by E1A leads to the induction of apoptosis in DNA-damaged cells.

Authors:  D Chattopadhyay; M K Ghosh; A Mal; M L Harter
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

Review 3.  Control of the G2/M transition.

Authors:  George R Stark; William R Taylor
Journal:  Mol Biotechnol       Date:  2006-03       Impact factor: 2.695

4.  RB reversibly inhibits DNA replication via two temporally distinct mechanisms.

Authors:  Steven P Angus; Christopher N Mayhew; David A Solomon; Wesley A Braden; Michael P Markey; Yukiko Okuno; M Cristina Cardoso; David M Gilbert; Erik S Knudsen
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

5.  HIV-1 viral infectivity factor interacts with TP53 to induce G2 cell cycle arrest and positively regulate viral replication.

Authors:  Taisuke Izumi; Katsuhiro Io; Masashi Matsui; Kotaro Shirakawa; Masanobu Shinohara; Yuya Nagai; Masahiro Kawahara; Masayuki Kobayashi; Hiroshi Kondoh; Naoko Misawa; Yoshio Koyanagi; Takashi Uchiyama; Akifumi Takaori-Kondo
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-11       Impact factor: 11.205

6.  Chromatin immunoprecipitation-based screen to identify functional genomic binding sites for sequence-specific transactivators.

Authors:  Jamie M Hearnes; Deborah J Mays; Kristy L Schavolt; Luojia Tang; Xin Jiang; Jennifer A Pietenpol
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

7.  Direct p53 transcriptional repression: in vivo analysis of CCAAT-containing G2/M promoters.

Authors:  Carol Imbriano; Aymone Gurtner; Fabienne Cocchiarella; Silvia Di Agostino; Valentina Basile; Monica Gostissa; Matthias Dobbelstein; Giannino Del Sal; Giulia Piaggio; Roberto Mantovani
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

8.  p53 Deletion or Hotspot Mutations Enhance mTORC1 Activity by Altering Lysosomal Dynamics of TSC2 and Rheb.

Authors:  Stuti Agarwal; Catherine M Bell; Shirley M Taylor; Richard G Moran
Journal:  Mol Cancer Res       Date:  2015-09-18       Impact factor: 5.852

9.  The Delta Np63 alpha phosphoprotein binds the p21 and 14-3-3 sigma promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells syndrome-derived mutations.

Authors:  Matthew D Westfall; Deborah J Mays; Joseph C Sniezek; Jennifer A Pietenpol
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

Review 10.  p53 and E2f: partners in life and death.

Authors:  Shirley Polager; Doron Ginsberg
Journal:  Nat Rev Cancer       Date:  2009-10       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.